Instil Bio Future Growth
Future criteria checks 0/6
Instil Bio is forecast to grow earnings and revenue by 54.1% and 62.6% per annum respectively while EPS is expected to grow by 63.7% per annum.
Key information
54.1%
Earnings growth rate
63.7%
EPS growth rate
Biotechs earnings growth | 24.8% |
Revenue growth rate | 62.6% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 10 May 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | N/A | -12 | N/A | N/A | 1 |
12/31/2025 | N/A | -75 | N/A | N/A | 3 |
12/31/2024 | N/A | -77 | N/A | N/A | 3 |
3/31/2024 | N/A | -123 | -74 | -62 | N/A |
12/31/2023 | N/A | -156 | -103 | -82 | N/A |
9/30/2023 | N/A | -197 | -139 | -106 | N/A |
6/30/2023 | N/A | -186 | -186 | -132 | N/A |
3/31/2023 | N/A | -226 | -233 | -160 | N/A |
12/31/2022 | N/A | -223 | -265 | -180 | N/A |
9/30/2022 | N/A | -225 | -276 | -186 | N/A |
6/30/2022 | N/A | -211 | -261 | -174 | N/A |
3/31/2022 | N/A | -188 | -228 | -159 | N/A |
12/31/2021 | N/A | -157 | -180 | -122 | N/A |
9/30/2021 | N/A | -119 | -181 | -96 | N/A |
6/30/2021 | 0 | -83 | -141 | -74 | N/A |
3/31/2021 | 0 | -57 | -104 | -45 | N/A |
12/31/2020 | 0 | -38 | -80 | -30 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TIL is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: TIL is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: TIL is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: TIL is forecast to have no revenue next year.
High Growth Revenue: TIL is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if TIL's Return on Equity is forecast to be high in 3 years time